Home > > > Arkansas HB 1297 AI Legislation: How AI-in-Billing Disclosure Could Impact Lab Revenue Cycle Systems

Arkansas HB 1297 AI Legislation: How AI-in-Billing Disclosure Could Impact Lab Revenue Cycle Systems

Author : Shawn Alfie | Published On : 17 Oct 2026

Arkansas HB 1297 and AI in Healthcare Insurance

Arkansas HB 1297 AI legislation was introduced as a proposal to regulate artificial intelligence, algorithms, and other automated technologies used by healthcare insurers. The bill addressed concerns about transparency and the role of AI in insurance utilization review and coverage decisions. Although HB 1297 did not become law and was withdrawn in 2025, its proposed requirements remain relevant to laboratories monitoring how payer-side AI could affect claims, utilization review, and reimbursement workflows.

The proposal reflected a broader national trend toward greater oversight of AI in healthcare. States have increasingly examined how insurers use automated systems for prior authorization, utilization management, claims processing, and coverage decisions. In Arkansas, HB 1297 specifically targeted healthcare insurers rather than creating a general AI disclosure requirement for laboratories.

For laboratories, the significance is indirect but important. A payer's AI system can influence whether a claim receives additional review, whether utilization criteria are triggered, or whether a service is questioned. As automated decision-support tools become more common, laboratories need revenue cycle systems capable of identifying unusual payer behavior and documenting the basis for disputed reimbursement decisions.

This makes lab billing and coding increasingly connected to payer technology. A laboratory may have accurate CPT coding, appropriate diagnosis information, complete documentation, and a valid payer contract, yet still encounter a payment reduction or denial generated through an automated workflow. Understanding how payer-side automation operates can therefore help billing teams investigate recurring patterns instead of treating every denial as an isolated claim problem.

What Did Arkansas HB 1297 Propose?

HB 1297 was designed around the use of AI and automated technologies by healthcare insurers. One of its key concepts was transparency concerning the strengths, limitations, and potential biases of AI algorithms used in utilization review. The proposal also addressed whether an algorithm could independently serve as the basis for decisions affecting healthcare services.

The proposal is important because utilization review decisions can have a downstream effect on healthcare providers and laboratories. If an insurer's automated system flags a laboratory service, the resulting review may delay payment or require additional documentation.

For laboratories, this creates a practical reason to maintain strong claim documentation. When a payer requests additional records or denies a claim, the laboratory should be able to demonstrate what service was performed, why it was ordered, which code was submitted, and what supporting documentation was available.

Why AI Oversight Matters to Laboratory Revenue Cycle Management

AI is increasingly being used to automate repetitive healthcare administrative tasks. In laboratory operations, automation can support eligibility checks, coding review, claim scrubbing, denial identification, payment posting, and accounts receivable analysis.

On the payer side, automated systems can also influence claim and utilization workflows. That means laboratories may interact with an increasingly automated reimbursement environment even when the laboratory itself does not use AI to make billing decisions.

This creates a new revenue cycle challenge: distinguishing a legitimate contractual or policy-based denial from a potentially incorrect automated decision.

A strong lab billing and coding services workflow can help laboratories review these situations systematically. Rather than automatically correcting or writing off a denied claim, staff can examine the remittance reason, payer policy, submitted codes, documentation, and claim history before deciding whether a correction or appeal is appropriate.

Potential Impact on Laboratory Claims

If similar AI transparency requirements become law in Arkansas or other states, laboratories could see several practical changes in their payer interactions.

More Transparency Around Automated Decisions

Greater disclosure requirements could make it easier for providers to understand when automated systems are involved in utilization review or related insurance processes. For laboratories, greater transparency could help explain why certain claims consistently receive additional review.

However, laboratories should not assume that every denial or payment reduction is generated by AI. Claims can be processed through multiple automated and human workflows, and the remittance advice remains an important source for determining the stated reason for an adjustment.

Greater Importance of Human Review

HB 1297's proposed approach included restrictions on using an algorithm as the sole basis for decisions to deny, delay, or modify care.

For laboratory revenue cycle teams, the broader principle is significant. Automated tools may identify claims for review, but complex reimbursement disputes still require appropriate human evaluation.

A laboratory should maintain an escalation process for claims involving unusual medical necessity determinations, inconsistent payer responses, unexpected coding edits, or repeated automated denials.

Better Denial Documentation

AI-related payer oversight could increase the importance of documenting denial patterns. Revenue cycle teams should track:

  • Payer and plan.

  • CPT and HCPCS codes involved.

  • Diagnosis codes submitted.

  • Denial and adjustment codes.

  • Date of service.

  • Authorization status.

  • Documentation requested by the payer.

  • Appeal outcome.

  • Amount originally billed.

  • Amount paid.

  • Remaining balance.

This information can reveal whether a particular payer, procedure, or claim type is experiencing recurring reimbursement problems.

AI, Claims Automation, and Underpayments

Underpayments are not limited to obvious payment errors. A claim can be processed successfully and still receive less reimbursement than expected.

Laboratories should compare actual payments against contractual rates and applicable reimbursement rules. If a claim appears underpaid, the billing team should determine whether the difference resulted from the contract, fee schedule, bundling, coding, coverage limitations, or an apparent processing error.

Automated payment analysis can make this process faster by identifying claims that fall outside expected payment ranges. However, automation should support the review rather than replace the underlying validation process.

A system that automatically flags a $100 payment variance is useful. A system that automatically labels the variance as an insurer error without checking the contract is not.

Preparing Laboratory Billing Systems for AI-Driven Payer Workflows

Laboratories do not need to wait for a new Arkansas AI law before improving their revenue cycle processes. Several practical steps can make billing operations more prepared for increasingly automated payer environments.

Standardize Claim Data

Accurate patient information, payer details, diagnosis codes, procedure codes, units, modifiers when applicable, and authorization information give automated systems better-quality data to work with and make human review easier when a claim is disputed.

Maintain Strong Documentation

Laboratory reports, orders, clinical indications, authorization records, and payer correspondence should be retained according to applicable requirements. Documentation becomes particularly important when a laboratory challenges a denial or payment decision.

Monitor Denial Patterns

A single denial may not indicate a systemic issue. Repeated denials involving the same payer, code, diagnosis, or reason can reveal a larger problem.

Revenue cycle managers should periodically analyze denial trends rather than reviewing claims only individually.

Build Human Escalation Into Automation

Automated claim scrubbing and denial-management tools should include escalation rules for unusual or high-value claims. Human reviewers should be able to investigate cases that involve conflicting information or significant reimbursement consequences.

Audit AI-Enabled Tools

Laboratories using AI-powered billing software should understand what the system is doing, what data it uses, and how its recommendations are reviewed. Staff should not assume that an automated coding or denial recommendation is correct simply because it was generated by software.

What Laboratories Should Watch in 2026

Although HB 1297 itself did not become an active Arkansas requirement, its subject matter reflects a broader regulatory direction. State lawmakers and regulators continue to examine AI use in healthcare, particularly when automated systems influence insurance decisions and patient access to care.

For laboratories, the most important development may not be a single state bill. It is the growing interaction between AI, payer operations, utilization review, claims processing, and revenue cycle management.

Laboratories should monitor state legislation, payer policies, contract updates, and technology changes that could affect how claims are evaluated.

The key objective is not to avoid automation. Properly controlled automation can reduce repetitive work and help billing teams identify errors faster. The objective is to ensure that automated processes remain auditable, accurate, and supported by appropriate human review.

Frequently Asked Questions

Is Arkansas HB 1297 currently law in 2026?

No. HB 1297 was introduced in Arkansas in 2025 as a proposal concerning AI and automated technologies used by healthcare insurers. It was withdrawn and did not become an active Arkansas law.

What would HB 1297 have required?

The proposal addressed transparency around AI algorithms used by healthcare insurers, including disclosure concerning their strengths, limitations, and potential biases. It also addressed the use of algorithms as the sole basis for certain healthcare coverage decisions.

Does HB 1297 directly regulate laboratory billing companies?

No. The proposal was directed primarily at healthcare insurers. Its potential relevance to laboratories comes from the way insurer AI and automated utilization-review systems can affect claims, payment decisions, and reimbursement workflows.

How can laboratories prepare for increased AI use by payers?

Laboratories can strengthen documentation, monitor denial and payment patterns, validate contractual reimbursement, maintain human review procedures, and audit automated billing and revenue cycle tools.

Can AI be used in laboratory revenue cycle management?

Yes. AI and automation can support administrative activities such as claim review, denial identification, payment analysis, and workflow prioritization. Laboratories should establish appropriate controls and human oversight for decisions that can materially affect claims or reimbursement.

Conclusion

Arkansas HB 1297 illustrates the broader regulatory discussion surrounding AI in healthcare insurance. Although the bill did not become law, its focus on transparency, algorithmic limitations, potential bias, and human involvement in healthcare decisions provides useful context for laboratories operating in an increasingly automated reimbursement environment.

For laboratory revenue cycle teams, the practical response is to strengthen the fundamentals: accurate coding, complete documentation, payer-specific reimbursement checks, detailed denial tracking, and systematic underpayment review. As insurers increasingly adopt automated technologies, laboratories that can audit claims, identify unusual payer patterns, and support disputed payments with clear documentation will be better positioned to protect revenue while maintaining compliant billing practices.